Monday, 19 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

FIN.ETANG BERRE Stock Over 24% Up So Far On Monday

Loading stream...

(vianews) - shares of fin.etang berre (cac 40: berr.pa) rose by a staggering 24.44% to €11.20 at 11:54 est on monday, after five successive sessions in a row of losses. cac 40 is dropping 0.53% to €7,125.53, after five sequential sessions in a row of losses. this seems, up to now, a somewhat negative trend trading session today.

about fin.etang berre

financiere et immobiliere de l'etang de berre et de la mediterranee société anonyme engages in the caravanning, and parking and restaurant rental businesses. financiere et immobiliere de l'etang de berre et de la mediterranee société was incorporated in 1971 and is headquartered in carry-le-rouet, france.

earnings per share

as for profitability, fin.etang berre has a trailing twelve months eps of €0.04.

pe ratio

fin.etang berre has a trailing twelve months price to earnings ratio of 280. meaning, the purchaser of the share is investing €280 for every euro of annual earnings.

more news about fin.etang berre (berr.pa).

Categories

stockMarket

Tags

Stock PriceMarket Session NowFIN.ETANG BERREStock Market NowPrice UpBERR.PAMarket SessionStock Price UpStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com